The National Institutes of Health has launched the NIH 3D Print Exchange, a public website that enables users to share, download and edit 3D print files related to health and science. These files can be used, for example, to print custom laboratory equipment and models of bacteria and human anatomy. Today's launch coincides with the first White House Maker Faire, an event designed to celebrate U.S. innovation in science, technology, engineering and math.
"3D printing is a potential game changer for medical research," said NIH Director Francis S. Collins, M.D., Ph.D. "At NIH, we have seen an incredible return on investment; pennies' worth of plastic have helped investigators address important scientific questions while saving time and money. We hope that the 3D Print Exchange will expand interest and participation in this new and exciting field among scientists, educators and students."
NIH uses 3D printing, or the creation of a physical object from a digital model, to study viruses, repair and enhance lab apparatus, and help plan medical procedures. The 3D Print Exchange makes these types of files freely available, along with video tutorials for new users and a discussion forum to promote collaboration. The site also features tools that convert scientific and clinical data into ready-to-print 3D files.
The 3D Print Exchange is a collaborative effort led by NIH's National Institute of Allergy and Infectious Diseases (NIAID). "3D printing is helping to advance science at NIAID and beyond," said NIAID Director Anthony S. Fauci, M.D. "The ability to design and print tangible models of pathogens, for example, can give researchers a fresh perspective on the diseases they study and open new and promising lines of investigation."
Additional support is provided by other NIH components, including the Eunice Kennedy Shriver National Institute of Child Health and Human Development and the National Library of Medicine. The 3D Print Exchange is funded in part by the U.S. Department of Health and Human Services through its Ignite and Ventures programs, which help support innovation within the agency.
NIAID conducts and supports research--at NIH, throughout the United States, and worldwide--to study the causes of infectious and immune-mediated diseases, and to develop better means of preventing, diagnosing and treating these illnesses. News releases, fact sheets and other NIAID-related materials are available on the NIAID Web site at http://www.
About the National Institutes of Health (NIH):
NIH, the nation's medical research agency, includes 27 Institutes and Centers and is a component of the U.S. Department of Health and Human Services. NIH is the primary federal agency conducting and supporting basic, clinical, and translational medical research, and is investigating the causes, treatments, and cures for both common and rare diseases. For more information about NIH and its programs, visit http://www.